Inhibrx Biosciences, Inc. Common Stock

INBXNASDAQ • USD
93.41 USD
↘ 1.15 (1.22%)AT CLOSE (03:59 PM EDT)
93.50
↗ 0.09 (0.09%)
POST MARKET (AS OF 04:20 PM EDT)
Post Market
AS OF 04:20 PM EDT
93.50
↗ 0.09 (0.09%)
🟢Market: OPEN

INBX is currently priced at $93.50. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (260.8%) and a bullish Golden Cross on the moving averages.

Technical & fundamental data as of Oct 5, 2026.

Open?$95.52
High?$96.96
Low?$92.60
Prev. Close?$94.56
Volume?168.9K
Avg. Volume?339.4K
VWAP?$94.83
Rel. Volume?0.50x
Bid / Ask
Bid?$67.08 × 100
Ask?$117.42 × 100
Spread?$50.34
Midpoint?$92.25
Valuation & Ratios
Market Cap?1.4B
Shares Out?14.7M
Float?9.6M
Float %?65.5%
P/E Ratio?N/A
P/B Ratio?-26.27
EPS?-$9.39
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Employees
110
Market Cap
1.4B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2024-05-28
Address
11025 N. TORREY PINES ROAD, SUITE 140
LA JOLLA, CA 92037
Phone: (858) 795-4220
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
1
Momentum?
23
Short Sent.?
36
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.69Distress
Confidence?65%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?35.21%Squeeze Risk
Short Interest?3.4M
Days to Cover?8.3
Free Float9.6M
Avg Daily Volume408.5K
Settlement Date2026-09-15
Financial Health
Current Ratio?5.07Strong
Quick Ratio?5.07Strong
Cash Ratio?4.75Strong
Debt/Equity?-3.33Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-26.27CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-11.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
260.8%STRONG▾
ROA?
S&P
3
-89.6%WEAK▾
Cash Flow & Enterprise
FCF?$-131899000
Enterprise Value?$1.4B
Fundamentals ratios updated end of day